Genomelink
Creating the infrastructure of consumer genomics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
$3.5m | Seed | ||
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 156 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Genomelink is a personal genomics company founded in 2017 by Tomohiro Takano and Yuta Matsuda. The company is headquartered in Berkeley, California, and has a global user base.
Tomohiro Takano, the CEO, has a background in the genomics industry, which provided him with the insights to start Genomelink. Yuta Matsuda, the CTO, brings his expertise in software development to the team. Their combined skills have been instrumental in building the Genomelink platform.
The company operates in the direct-to-consumer genetic testing market. Its business model is based on a freemium model. Users can upload their raw DNA data from other genetic testing companies, such as AncestryDNA and 23andMe, to receive a limited number of free trait reports. For access to a more extensive range of reports and personalized insights, users can subscribe to a premium plan.
Genomelink's service provides a comprehensive analysis of a user's genetic data, offering insights into various aspects of their lives, including physical characteristics, personality traits, cognitive abilities, and wellness. The platform presents this information in an accessible and user-friendly manner, with detailed explanations and scientific references.
Keywords: genomics, DNA analysis, personal genetics, bioinformatics, direct-to-consumer genetics, trait reports, personalized insights, wellness, subscription model, genetic testing